US Patent Issued to ImmunityBio on Dec. 9 for "Modified NK-92 haNK003 cells for the clinic" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,377, issued on Dec. 9, was assigned to ImmunityBio Inc. (San Diego).

"Modified NK-92 haNK003 cells for the clinic" was invented by Hans Klingemann (Boston), Laurent Boissel (Boston) and Patrick Soon-Shiong (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are populations of modified NK-92 cells, compositions and kits comprising the cells, and methods of making and using the populations of cells."

The patent was filed on July 18, 2023, under Application No. 18/223,338.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetah...